TMPRSS11A and metabolic syndrome: In conclusion, correlation analysis of data from the HATFF study indicates that the responses of optimised Glo1 inducer, tRES-HESP, are linked to improvements in dysglycemia, blood pressure, dyslipidemia, and low-grade inflammation.